Physician Assistant, Surgical · Wilmington, NC
NPI
1922194596
Since 2006
Specialty
Physician Assistant, Surgical
Code 363AS0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2421 Silver Stream Ln
Wilmington, NC, 28401
Phone (910) 341-3300
Groups this clinician bills Medicare through
Medicare paid, 2024
$595K
57,255 services
Medicare patients, 2024
312
Average age 72
Drug cost, 2024
$5.3M
3,767 prescriptions
Company payments, 2025
$1,970
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawrence P Landrigan Jr. was code J3262 (injection, tocilizumab, 1 mg), 32,161 times for 13 patients. In total Lawrence P Landrigan Jr. billed 57,255 services in 72 codes, and Medicare paid $595K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 32,161 | 13 | $4.71 | $151K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 4,250 | 11 | $33.96 | $144K |
| Q5121 Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | Office | 2,380 | 11 | $16.12 | $38K |
| J0897 Injection, denosumab, 1 mg | Office | 1,020 | 13 | $20.69 | $21K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 542 | 50 | $0.70 | $381 |
| 99214 Office E&M - Established | Office | 490 | 252 | $71.88 | $35K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 434 | 242 | $9.67 | $4,195 |
| 36415 Venipuncture Blood Collection | Office | 419 | 233 | $8.59 | $3,600 |
| 86140 Clinical Chemistry | Office | 362 | 210 | $5.03 | $1,820 |
| 80053 Clinical Chemistry | Office | 343 | 184 | $10.23 | $3,509 |
| 96365 Intravenous Infusion, Hydration | Office | 231 | 58 | $38.14 | $8,811 |
| 96375 Injection Administration | Office | 168 | 39 | $9.43 | $1,583 |
| 96372 Injection Administration | Office | 153 | 64 | $8.44 | $1,292 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 152 | 12 | $0.09 | $13.49 |
| J1720 Injection, hydrocortisone sodium succinate, up to 100 mg | Office | 114 | 24 | $14.75 | $1,682 |
By year: 2022 $257K for 17,719 services; 2023 $167K for 15,462 services; 2024 $595K for 57,255 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 419 | 233 | $8.59 | $3,600 |
| 86140 Clinical Chemistry | 362 | 210 | $5.03 | $1,820 |
| 80053 Clinical Chemistry | 343 | 184 | $10.23 | $3,509 |
| 85652 Clinical Chemistry | 86 | 74 | $2.65 | $228 |
| 86705 Immunoassay | 47 | 47 | $11.53 | $542 |
| 86803 Immunoassay | 47 | 47 | $13.98 | $657 |
| 87340 Immunoassay | 46 | 46 | $10.12 | $466 |
| 86706 Immunoassay | 40 | 40 | $10.53 | $421 |
| 82306 Clinical Chemistry | 25 | 21 | $29.01 | $725 |
| 86200 Immunoassay | 24 | 24 | $12.69 | $305 |
Medicare prescription drug claims, 2024
In 2024, the drug Lawrence P Landrigan Jr. prescribed most often to Medicare patients was Prednisone, with 758 prescriptions and refills. In total Lawrence P Landrigan Jr. wrote 3,767 Medicare prescriptions that cost $5.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 758 | 943 | 207 | $3,434 |
| Methotrexate Methotrexate Sodium | 647 | 1,232 | 155 | $12K |
| Hydroxychloroquine Sulfate Generic | 441 | 967 | 116 | $14K |
| Leflunomide Generic | 189 | 396 | 61 | $15K |
| Rinvoq Upadacitinib | 149 | 151 | 20 | $1.0M |
| Enbrel Sureclick Etanercept | 110 | 114 | 16 | $847K |
| Allopurinol Generic | 109 | 284 | 29 | $1,137 |
| Meloxicam Generic | 92 | 168 | 31 | $334 |
| Humira(Cf) Pen Adalimumab | 87 | 89 | 13 | $638K |
| Duloxetine Hcl Generic | 85 | 189 | 19 | $1,126 |
| Celecoxib Generic | 83 | 141 | 18 | $1,396 |
| Sulfasalazine Generic | 70 | 146 | 21 | $2,046 |
| Simponi Golimumab | 70 | 75 | Under 11 | $472K |
| Leucovorin Calcium Generic | 69 | 162 | 19 | $1,143 |
| Orencia Clickject Abatacept | 51 | 53 | Under 11 | $312K |
Brand drugs: - claims; generic drugs: 2,858 claims; opioid claims: 39.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawrence P Landrigan Jr. $1,970 ($1,970 in general payments such as food, travel and fees) from 17 companies. The largest payer was Amgen Inc. with $484.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 25 | $484 |
| Pfizer Inc. PFE | 23 | $243 |
| UCB, Inc. UCB.BR | 10 | $233 |
| Abbvie Inc. ABBV | 8 | $167 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $166 |
| Lilly USA, LLC LLY | 5 | $104 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $88.88 |
| Radius Health, Inc. | 4 | $88.66 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $67.99 |
| Organon LLC OGN | 3 | $64.43 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.